Regulation of key antiplatelet pathways by bioactive compounds with minimal bleeding risk

11Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Cardiovascular disease is strongly influenced by platelet activation. Platelet activation and thrombus formation at atherosclerotic plaque rupture sites is a dynamic process regulated by different signaling networks. Therefore, there are now focused efforts to search for novel bioactive compounds which target receptors and pathways in the platelet activation process while preserving normal hemostatic function. The antiplatelet activity of numerous fruits and vegetables and their multiple mechanisms of action have recently been highlighted. In this review, we review the antiplatelet actions of bioactive compounds via key pathways (protein disulfide isomerase, mitogen-activated protein kinases, mitochondrial function, cyclic adenosine monophosphate, Akt, and shear stress-induced platelet aggregation) with no effects on bleeding time. Therefore, targeting these pathways might lead to the development of effective antiplatelet strategies that do not increase the risk of bleeding.

Cite

CITATION STYLE

APA

Fuentes, E., Wehinger, S., & Trostchansky, A. (2021, November 1). Regulation of key antiplatelet pathways by bioactive compounds with minimal bleeding risk. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms222212380

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free